Last update 21 Nov 2024
NT-112
Last update 21 Nov 2024
Overview
Basic Info
Drug Type TCR therapy |
Synonyms |
Target |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization  Neogene Therapeutics, Inc.Startup |
Active Organization Neogene Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with NT-112An Open-label, Phase 1, Multicenter Study to Evaluate the Safety and Preliminary Anti-tumor Activity of NT-112 in Human Leukocyte Antigen-C*08:02-Positive Adult Subjects with Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive for the KRAS G12D Mutation
100 Clinical Results associated with NT-112
Login to view more data
100 Translational Medicine associated with NT-112
Login to view more data
100 Patents (Medical) associated with NT-112
Login to view more data
100 Deals associated with NT-112
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 1 | US | Neogene Therapeutics, Inc.Startup | 05 Feb 2024 |
| Endometrial Carcinoma | Phase 1 | US | Neogene Therapeutics, Inc.Startup | 05 Feb 2024 |
| Non-Small Cell Lung Cancer | Phase 1 | US | Neogene Therapeutics, Inc.Startup | 05 Feb 2024 |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | US | Neogene Therapeutics, Inc.Startup | 05 Feb 2024 |
| Solid tumor | Preclinical | NL | Neogene Therapeutics, Inc.Startup | 27 Jul 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free